Copyright
©The Author(s) 2025.
World J Nephrol. Sep 25, 2025; 14(3): 108406
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.108406
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.108406
Table 1 Comparison of saliva collection methods based on biomarker reliability, feasibility, and limitations
Collection method | Biomarker reliability | Feasibility | Major limitations |
Spitting | High | Easy and patient-friendly | Inconsistent flow, variable technique |
Passive drool | Moderate to high | Non-invasive, simple | Slow collection, risk of evaporation |
Stimulated (paraffin chewing) | Moderate (flow-dependent dilution) | Simple, cost-effective | Contamination risk, requires compliance, time-sensitive processing |
Stimulated (parotid) | Variable, biomarker-specific | Targeted gland sampling | Invasive, discomfort, specialized equipment needed |
Oral rinse | Low (due to dilution) | Very easy and rapid | Dilution effect, unreliable concentrations |
Salivette® | Moderate | Standardized device available | Absorption variability, potential contamination |
Table 2 Summary of studies on salivary creatinine and urea for chronic kidney disease diagnosis
Ref. | Biomarker(s) | Sample size (CKD/control) | CKD stage(s) | Collection method | Statistical analysis | Correlation (r) | AUC | Assay type | Key findings | Limitations |
Venkatapathy et al[61], 2014 | Creatinine | 105/37 | Stage 4-5 | Spitting | T-test, pearson, linear regression, ROC | 0.73 | 0.96 (97.1% sensitivity and 86.5% specificity) | Enzymatic | High diagnostic accuracy in advanced CKD | No early-stage CKD data |
Lasisi et al[57], 2016 | Creatinine, urea | 49/50 | Mostly stage 4–5 | Spitting | Mann-Whitney U, Spearman, ROC | Creatinine = 0.69, urea = 0.51 | Creatinine: 0.97 (94% sensitivity and 85% specificity, urea: 0.89 (86% sensitivity and 93% specificity) | Enzymatic | Reflects serum levels, high diagnostic accuracy | Lacked early-stage representation |
Pandya et al[62], 2016 | Creatinine, urea | 90/30 | Not specified | Spitting | Kruskal-Wallis, Mann-Whitney U, Spearman | Creatinine = 0.97; urea = 0.97 | NR | Enzymatic | Significant serum-saliva correlation | Variability in flow rate, method inconsistency |
Pham[60], 2017 | Creatinine, urea | 112/108 | All stages | Spitting | Spearman, linear regression, ROC | Creatinine = 0.90; urea = 0.73 | Creatinine: 0.92 (86.5% sensitivity 87.2% and specificity), urea: 0.76 (82.9% sensitivity and 57.8% specificity | Spectrophotometric | Validated diagnostic utility in large sample | Cross-sectional, urban-based sampling bias |
Bagalad et al[63], (2017) | Creatinine, urea | 41/41 | Not specified | Spitting | T-test, pearson, ROC | Creatinine = 0.65; urea = 0.81 | Creatinine: 0.9 (93.0% sensitivity and 93.0% specificity), urea: 0.9 (93.0% sensitivity and 90.0% specificity) | Enzymatic | High diagnostic accuracy demonstrated | Inconsistencies in collection and assay protocols |
Renda[56], 2017 | Creatinine | 35/28 | Not specified (Pediatric) | Spitting | Kolmogorov-Smirnov, pearson, linear regression, ROC | r = 0.79 | 0.80 (82.9% sensitivity and 78.6% specificity) | Enzymatic | Strong serum-saliva correlation | Pediatric-only, small sample, no adult comparison |
Nagarathinam et al[59], 2023 | Urea | 150/30 | Stage 1–5 | Spitting | T-test, ANOVA, pearson, ROC | 0.51 ≈ 0.75 | 0.91 (88% sensitivity and 84% specificity) | Enzymatic | Strong stage-wise diagnostic potential | Periodontal status, diet, hydration not controlled |
Liyanage et al[64], 2024 | Creatinine, urea | 100/0 | Stage 2–5 | Spitting | Pearson, paired t-test, χ2, ROC | Creatinine = 0.98; urea = 0.94 | ≥ 0.99 (sensitivity and specificity: NR) | Enzymatic | Correlations unaffected by age/sex | No healthy controls included for comparison |
Table 3 Summary of studies on salivary calcium and parathyroid hormone for chronic kidney disease diagnosis
Ref. | Biomarker(s) | Sample size (CKD/control) | CKD stage(s) | Collection method | Statistical analysis | Correlation (r) | AUC | Assay type | Key findings | Limitations |
Rodrigues et al[65], 2016 | Calcium, PTH | 60/37 | Stage 5 | Stimulated (paraffin chewing) | T-test, pearson, simple linear regression | Calcium: -0.13, PTH: 0.03 | NR | Colorimetric | No significant correlation between serum and saliva | Small sample size |
Rajolani et al[66], 2024 | Calcium, PTH | 29/0 | NR | Spitting method | Paired t-test, pearson's correlation | NR | NR | Enzymatic | No significant serum-saliva correlation for calcium and PTH | Healthy controls are needed for better comparison |
- Citation: Abu Raihan Uddin M, Tuan Ismail TS, Wan Nik WNFH, Arifin WN, Isa S. Saliva as a non-invasive biomarker for chronic kidney disease: Challenges and potential in disease monitoring. World J Nephrol 2025; 14(3): 108406
- URL: https://www.wjgnet.com/2220-6124/full/v14/i3/108406.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i3.108406